Ms. Quish is a Managing Director based in Menlo Park for the Fortress Credit Funds Business where she heads Asset Management for Fortress’s Intellectual Property Finance Group. In this role, she provides counsel and advice to portfolio companies that are engaged in monetization efforts. Ms. Quish has 20 years of experience assessing and monetizing patent assets. Prior to joining Fortress in 2018, Ms. Quish held the position of Vice President of Patent Strategy and M&A at Rovi Corporation, a TiVo Company where she was responsible for leading patent acquisitions and patent-heavy corporate acquisitions as well as designing and implementing IP monetization strategies. Prior to joining Rovi, Ms. Quish was a Member of Mintz Levin’s patent litigation practice where she spent the majority of her time representing patent owners in licensing and litigation matters including litigation in U.S. district courts and the International Trade Commission. Ms. Quish has been recognized by Intellectual Asset Magazine on a number of occasions, including being identified as one of the World’s Global Leaders in IP and the World’s Leading IP Strategists, where individuals are recognized for their experience related to creating and enforcing critical patent rights to help maximize the value of IP portfolios. In the past, Ms. Quish was also identified as one of the 40 world “Elite Dealmakers” and 1 of 10 “IP Personalities” by the same publication. Ms. Quish earned her J.D. from the University of Michigan Law School and her B.A. with High Honors from Middlebury College.
The Case for RESTORE? Injunctions, Patents, and the Future of Innovation
Ryan T. Holte, Andrei Iancu, Adam Mossoff, Kristen Osenga, Chris Storm
Join the Federalist Society for a timely and compelling discussion on the RESTORE Act, legislation...
Litigation Transparency Act of 2025: Patents, Policy, and Legal Ethics
Kacie Donovan, Kristen Osenga, Courtney Quish, Jonathan Stroud, Paul Brian Taylor
Prompted by the reintroduction of federal Litigation Transparency Act legislation, this panel will address a...
Innovation in Diagnostics and Patent Subject Matter Eligibility
Paul R. Gugliuzza, Andrew Halaby, David J. Kappos, David O. Taylor
This teleforum will focus on patent subject matter eligibility issues highlighted by the COVID-19 pandemic,...
Should Congress Amend Section 101 of the Patent Act?
Philip Johnson, Adam Mossoff, Dana S. Rao, Robert Sachs
This Teleforum addresses whether there is a need to amend Section 101 of the Patent...
Should Congress Amend Section 101 of the Patent Act?
Intellectual Property Practice Group
TeleforumFTC’s 6(b) Patent Assertion Entity Study - Podcast
Jorge L. Contreras, Kristen Osenga, Laurie Self, Adam Mossoff
On October 6, 2016, the Federal Trade Commission released the long-awaited results of its 6(b)...
What’s at Stake in Cuozzo v. Lee?: The View of the Petitioner
David L. Applegate
Currently pending on the docket of the United States Supreme Court is the case of...
The Costs of Patent Reform: Early Data and Abuses in the Uneven Playing Field of Post-Issuance Review
Gregory Dolin
Note from the Editor: This article is a critical examination of patent reform. As always,...